Inhibitory effects of anti-rheumatic drugs containing magnosalin, a compound from 'Shin-i' (Flos magnoliae), on the proliferation of synovial cells in rheumatoid arthritis models

Immunopharmacology

Volumn 39, Issue 2, 1998, Pages 139-147

  Kobayashi, Shinjiro ^a,b   Kobayashi, Hideo ^a   Matsuno, Hiroaki ^a   Kimura, Ikuko ^a   Kimura, Masayasu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

Author keywords

Collagen induced arthritis; Cytokine; Interleukin 1 ; Magnosalin; MRL 1pr mouse; Rheumatoid arthritis patients; Synovial cell

Indexed keywords

ANTIRHEUMATIC AGENT; INTERLEUKIN 1ALPHA; MAGNOSALIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; FEMALE; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELL DIVISION; CYCLOBUTANES; CYTOKINES; INTERLEUKIN-1; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED MRL LPR; SYNOVIAL MEMBRANE; THYMIDINE;

EID: 0031853413     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(98)00004-6     Document Type: Article

References (40)

1. Arnett, F.C., Edworthy, S.M., Bloch, D.A., Mcshane, D.J. et al., 1987. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315-324.
2. Brennan, F.M., Zachariae, C.O., Chantry, D., Larsen, C.G., Turrner, M., Maini, R.N., Matsushima, K., Feldmann, M., 1990. Detection of interleukin-8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin-8 mRNA by isolated synovial cells. Eur. J. Immunol. 20, 2141-2144.
3. Bucala, R., Ritchin, C., Winchester, R., Cerami, A., 1991. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblast. J. Exp. Med. 173, 569-574.
4. Butler, D.M., Piccoli, D.S., Hart, P.H., Hamilton, J.A., 1988. Stimulation of human synovial fibroblast DNA synthesis by recombinant human cytokines. J. Rheumatol. 15, 1463-1470.
5. Butler, D.M., Leizer, T., Hamilton, J.A., 1989. Stimulation of human synovial fibroblast DNA synthesis by platelet-derived growth factor. Difference to the activation by IL-1. J. Immunol. 142, 3098-3103.
6. Courtenary, J.S., Dallman, M.J., Dayan, A.D., Martin, A., Mosedale, B., 1980. Immunization against heterologous type II collagen induces arthritis in mice. Nature 283, 666-668.
7. Dayer, J.-M., Krane, S.M., Russell, R.G.G., Robinson, D.R., 1976. Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cell. Proc. Natl. Acad. Sci. U.S.A. 73, 945-949.
8. Fassbender, H.G., 1984. Current understanding of rheumatoid arthritis. Inflammation 8, S27-S42.
9. Firestein, G.S., Alvaro-Gracia, J.M., Maki, R., 1990. Quantitative analysis of cytokines gene expression in rheumatoid arthritis. J. Immunol. 144, 3347-3353.
10. Goto, M., Sasano, M., Yamanaka, N., Miyasaka, N., Inoue, K., Nishioka, K., Miyamoto, T., 1987. Spontaneous production of interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. J. Clin. Invest. 80, 786-796.
11. Hayashi, M., Matsunaga, K., Okahara, A., Mita, S., 1991. Effect of bucillamine (SA96) on type II collagen-induced arthritis in rats. J. Rheumatol. 18, 691-695.
12. Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sata, K., Shimizu, M., Maini, R., Feldmann, M., Kishimoto, T., 1988. Excessive production of interleukin-6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur. J. Immunol. 18, 1797-1801.
13. Hirata, S., Matsubara, T., Saura, R., Tateishi, H., Hirohata, K., 1989. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate. Arthritis Rheum. 32, 1065-1073.
14. Holmdahl, R., Gullberg, D., Forsberg, P.O., Jansson, L., Rubin, K., Klareskog, L., 1985. Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II Clin. Exp. Immunol. 62, 639-646.
15. Houssiau, F.A., Devogelaer, J.P., van Damme, J., de Deuxchaisnes, C.N., van Snick, J., 1988. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritis. Arthritis Rheum. 31, 784-788.
16. Kawakami, A., Eguchi, K., Ueki, Y., 1991. Effect of lobenzarit disodium on human endothelial cells. Lobenzarit disodium inhibits proliferative response, HLA-DR antigen expression and T-cell adherence toward endothelial cells. Arthritis Rheum. 34, 296-303.
17. Kikuchi, T., Kadota, S., Yanada, K., Tanaka, K., Watanabe, K., Yoshizaki, M., Yokoi, T., Shingu, T., 1983. Isolation and structure of magnosalin and magnoshinin, new neolignans from Magnolia salicifolia Maxim. Chem. Pharm. Bull. 31, 1112-1114.
18. Kimura, I., Nagaura, T., Kobayashi, S., Kimura, M., 1992. Inhibitory effects of magnoshinin and magnosalin, compounds from 'Shin-i' (Flos Magnoliae), on the competence and progression phase in proliferation of subcultured rat aortic endothelial cells. Jpn. J. Pharmacol. 60, 59-62.
19. Kimura, M., Suzuki, J., Yamada, T., Yoshizaki, M., Kadota, S., Matsuda, S., 1985. Anti-inflammatory effect of neolignans newly-isolated the crude drug 'Shin-i' (Flos Magnoliae). Planta. Med. 51, 291-293.
20. Kimura, M., Kobayashi, S., Luo, B., Kimura, I., 1990. Selective inhibition by magnosalin and magnoshinin, compounds from 'Shin-i' (Flos magnoliae), of adjuvant-induced angiogenesis and granuloma formation in the mouse pouch. Int. Arch. Allergy Appl. 93, 365-370.
21. Kobayashi, S., Kimura, I., Kimura, M., 1996. Inhibitory effect of magnosalin derived from Flos magnoliae on tube formation of rat vascular endothelial cells during the angiogenic process. Biol. Pharm. Bull. 19, 1304-1306.
22. Kobayashi, S., Nagaura, T., Kimura, I., Kimura, M., 1994. Interferon-γ-activated macrophages enhance angiogenesis from endothelial cells of rat aorta. Immunopharmacology 27, 23-30.
23. Kobayashi, S., Okabe, M., Kimura, I., Kimura, M., 1995. Interferon-γ-activated macrophages release interleukin-1α to increase tube formation from endothelial cells of rat aorta. Immunopharmacology 31, 93-101.
24. Krane, S., Dayer, J.M., Goldring, S.R., 1982. Consideration of possible cellular events in the destructive synovial lesion of rheumatoid arthritis. Adv. Inflamm. Res. 3, 1-15.
25. Matsubara, T., Ziff, M., 1987. Inhibition of human endothelial cell proliferation by gold compounds. J. Clin. Invest. 79, 1440-1446.
26. Matsubara, T., Hirohata, K., 1988. Suppression of human fibroblast proliferation by D-penicillamine and copper sulfate in vitro. Arthritis Rheum. 31, 964-972.
27. Matsubara, T., Satsuma, S., Kuroda, T., Hirohata, K., 1990. The effect of D-penicillamine on the proliferation of human endothelial cells and synovial fibroblastic cells. Jpn. J. Inflamm. 10, 493-497.
28. Matsuno, H., Matsusita, I., Okada, C., Suzuki, M., Tsuji, H., Ochiai, H., 1991. Role of lymphocytes in collagen-induced arthritis. J. Rheumatol. 18, 1344-1349.
29. Meyer, F.A., Yaron, I., Mashiah, V., Yaron, M., 1993. Methotrexate inhibits proliferation but not interleukin-1-stimulated secretary activities of cultured human synovial fibroblasts. Rheumatolology 20, 238-242.
30. Melnyk, V.O., Shipley, G.D., Sternfeld, M.D., Sherman, L., Rosenbaum, J.T., 1990. Synoviocytes synthesize, bind, and respond to basic fibroblast growth factor. Arthritis Rheum. 33, 493-500.
31. Murphy, E.D., Roths, J.B., 1976. A single gene model for massive lymphoproliferation with immune complex disease in new mouse strain MRL. Proc. 16th Int. Congr. Hematol. Excerpta Medica, Amsterdam, pp. 69-72.
32. Patterson, M.K. Jr., 1979. Measurement of growth and viability of cells in culture. Methods Enzymol. 58, 141-152.
33. Priestley, G.C., Brown, J.C., 1980. Effect of corticosteroids on the proliferation of normal and abnormal human connective tissue cells. Br. J. Dermatol. 102, 35-41.
34. Pollack, S., Etzioni, A., 1992. Macrophages in autoimmunity and primary immunodeficiency. In: Lewis, C.E., Mcgee, J.O.D. (Eds.), The Macrophage: The Natural Immune System. Oxford, IRL Press, pp. 285-313.
35. Remmers, E., Lafyatis, R., Kumkumian, G.K., Case, J.S., Roberts, A.B., Sporn, M.B., Wilder, R.L., 1990. Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. Growth factors 2, 179-188.
36. Takahashi, K., Kobayashi, H., Kobayashi, S., Kimura, I., Terasawa, K., Kimura, M., 1996. Anti-proliferative effects of magnosalin derived from 'Shin-i' (Flos magnoliae), a Japanese Sino-medicine, on cultured synovial cells of MRL/1 and C57BL/6J mice. Phytother. Res. 10, 42-48.
37. Trentham, D.E., Townes, A.S., Kang, A.H., 1977. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 146, 857-868.
38. Trentham, D.E., 1982. Collagen arthritis as a relevant model for rheumatoid arthritis. Evidence pro and con. Arthritis Rheum. 25, 911-916.
39. Wood, D.D., Ihrie, E.J., Dinarello, C.A., Cohen, P.L., 1983. Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum. 26, 975-983.
40. Wooley, P.H., Luthra, H.S., Stuart, J.M., David, C.S., 1981. Type II collagen-induced arthritis in mice: Part I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154, 688-700.